Idenix Prices $70.3M Offering on Basis of Stock's Strength
By Marie Powers
Thursday, November 17, 2011
Idenix Pharmaceuticals Inc. took advantage of the tailwind in its stock, which on Tuesday hit a 52-week high of $7.38, by pricing a public offering disclosed one day earlier.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.